ruthenium has been researched along with Carcinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Dürst, M; Görls, H; Häfner, N; Hildebrandt, J; Kritsch, D; Runnebaum, IB; Weigand, W | 1 |
| Das, U; P K, A; Paira, P; Roy, N; Sahoo, SK; Varddhan, S | 1 |
| Batista, AA; Cerqueira, IH; Costa, AR; de Araujo-Neto, JH; De Grandis, RA; Demidoff, FC; Guedes, APM; Marques, WG; Moraes, CAF; Netto, CD; Pavan, FR; Resende, FA; Sampaio, NZ | 1 |
| Bergamo, A; Habtemariam, A; Masi, A; Peacock, AF; Sadler, PJ; Sava, G | 1 |
| ALTSHULER, B; DANIELS, M; HARLEY, JH; KUSCHNER, M; LASKIN, S; NELSON, N | 1 |
| Berger, W; Heffeter, P; Jakupec, MA; Kapitza, S; Keppler, BK; Lackinger, L; Marian, B; Pongratz, M | 1 |
| Alessio, E; Bergamo, A; Capozzi, I; Cocchietto, M; Mestroni, G; Sava, G | 1 |
| Alessio, E; Capozzi, I; Clerici, K; Gagliardi, G; Mestroni, G; Sava, G | 1 |
| Berdel, WE; Keppler, BK; Kreuser, ED; Piest, A; Thiel, E | 1 |
| Berger, MR; Keppler, BK; Seelig, MH | 1 |
| Alessio, E; Bregant, F; Ceschia, V; Mestroni, G; Pacor, S; Sava, G | 1 |
11 other study(ies) available for ruthenium and Carcinoma
| Article | Year |
|---|---|
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Resistance, Neoplasm; Female; Histones; Humans; Ligands; Molecular Structure; Organometallic Compounds; Osmium; Ovarian Neoplasms; Ruthenium | 2022 |
[Ru(η
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carcinoma; Cell Line, Tumor; Chemistry, Pharmaceutical; Coordination Complexes; Cymenes; Humans; Oxyquinoline; Ruthenium; Tissue Distribution; Zebrafish | 2022 |
Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Male; Phenanthrolines; Reactive Oxygen Species; Ruthenium | 2022 |
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Matrix Metalloproteinases; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Organometallic Compounds; Osmium; Ruthenium | 2010 |
CARCINOMA OF THE LUNG IN RATS EXPOSED TO THE BETA-RADIATION OF INTRABRONCHIAL RUTHENIUM PELLETS. I. DOSERESPONSE RELATIONSHIPS.
Topics: Animals; Carcinoma; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Radiation-Induced; Research; Ruthenium | 1963 |
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.
Topics: Apoptosis; Carcinoma; Colorectal Neoplasms; Humans; Indazoles; Mitochondria; Organometallic Compounds; Ruthenium; Salts; Tumor Cells, Cultured | 2005 |
Treatment of residual metastases with Na[trans-RuCl4 (DMSO)lm] and ruthenium uptake by tumor cells.
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm, Residual; Organometallic Compounds; Ruthenium; Survival Analysis | 1996 |
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Female; Flow Cytometry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Ruthenium | 1998 |
Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines.
Topics: Carcinoma; Colonic Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Interferon-alpha; Interferon-beta; Interferon-gamma; Interferons; Ruthenium; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1992 |
Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Imidazoles; Indazoles; Male; Organometallic Compounds; Rats; Rats, Inbred Strains; Ruthenium | 1992 |
Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].
Topics: Animals; Antineoplastic Agents; Carcinoma; Cisplatin; Imidazoles; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Organometallic Compounds; Ruthenium; Survival Analysis | 1991 |